Hemoptysis

28 registered clinical trials studyying Hemoptysis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Tranexamic Acid : Nebulization vs IV Route for Hemoptysis NCT07212452	University of Health Sciences Lahore	Phase 2 / Phase 3
Completed	Prophylactic Tranexamic Acid Versus Adrenaline During Flexible Bronchoscopy NCT06145191	Clinical Hospital Centre Zagreb	N/A
Completed	Single Use Flexible Bronchoscopes in Interventional Pulmonary Procedures NCT06144398	Clinical Hospital Centre Zagreb	N/A
Completed	An Exploratory Study on the Application of Transarterial CT Angiography in the Interventional Treatment of Mas NCT05786781	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	N/A
Completed	Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019 NCT05513248	Lung Center of the Philippines	—
Recruiting	Utility of Bronchoscopy in Patients With Haemoptysis and Negative Chest CT Scan (ULYSSES) NCT05634200	University of Milan	—
Unknown	Development and Application of a New Balloon Catheter for Intraairway Hemostasis NCT05554731	First Affiliated Hospital of Wenzhou Medical University	N/A
Withdrawn	Tc99m Macroaggregated Albumin Bronchial Artery Study NCT04555564	Johns Hopkins University	N/A
Recruiting	ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Tri NCT04961528	Assistance Publique - Hôpitaux de Paris	Phase 3
Unknown	TXA Nebulization for the Treatment of Hemoptysis NCT05648656	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 3
Unknown	Study of the Role of Hemostasis in Perioperative Anaphylaxis NCT04825158	University Hospital, Strasbourg, France	—
Completed	Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding NCT04771923	Clinical Hospital Centre Zagreb	N/A
Completed	Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy. NCT04770675	Qmed Consulting A/S	—
Completed	Prevalence Of Pulmonary Embolism In Patients With HEmoptysis (POPEIHE) NCT06067997	Società Italiana di Medicina di Emergenza-Urgenza	—
Completed	Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy NCT03824366	Washington University School of Medicine	N/A
Completed	Comparison of Intubation With Direct Laryngoscopy or Videolaryngoscopy in an Hemoptysis Simulated Situation on NCT04087135	Université de Montréal	N/A
Terminated	Efficacy and Safety of Argon Plasma Coagulation in the Treatment of Patients With Hemoptysis Caused by Endobro NCT03625947	University of Milan	—
Completed	Prophylactic Topical Epinephrine to Reduce Bleeding in Transbronchial Lung Biopsies NCT03126968	University of Maryland, Baltimore	Phase 2 / Phase 3
Unknown	A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection NCT03270735	Lee's Pharmaceutical Limited	Phase 4
Completed	Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and Hemopt NCT04079400	Gachon University Gil Medical Center	—
Unknown	Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis NCT02913365	Université de Sherbrooke	—
Completed	Complications After CT-guided Lung Biopsies at St. Olavs Hospital NCT07528170	St. Olavs Hospital	—
Completed	Bronchial Artery Embolization and Medical Measures in Non Severe Acute Hemoptysis of Mild-moderate Abundance NCT01278199	Assistance Publique - Hôpitaux de Paris	N/A
Withdrawn	Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis NCT01167764	Seoul National University Hospital	Phase 3
Completed	Efficacy of Tranexamic Acid in Hemoptysis NCT02781597	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 3
Completed	Urokinase Like Plasminogen Activator Levels in Patients Undergoing Bronchoscopy NCT00929565	University of Oklahoma	—
Completed	The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis NCT01171768	Samsung Medical Center	—
Completed	Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB NCT00387374	National Cancer Institute (NCI)	Phase 2